Not applicableLooking for participantsNCT01094327What this trial is testingProteinuria in Pre and Post TransplantWho this might be right forProteinuria University of Miami 100
Testing effectiveness (Phase 2)WithdrawnNCT05599815What this trial is testingPart 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic SyndromeWho this might be right forNephrotic Syndrome Aldeyra Therapeutics, Inc.
Not applicableActive Not RecruitingNCT02194582What this trial is testingGenetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureWho this might be right forFocal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more Beth Israel Deaconess Medical Center 2,050
Not applicableLooking for participantsNCT05505500What this trial is testingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.Who this might be right forFluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more University of Michigan 150
Testing effectiveness (Phase 2)Study completedNCT03366337What this trial is testingTrial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIXWho this might be right forIgA NephropathyCKD Associated With Type 1 DiabetesFocal Segmental Glomerulosclerosis+1 more Biogen 103
Not applicableNot Yet RecruitingNCT07010250What this trial is testingEpithelial Dysmetabolism and Renal Fibrosis in ANCA VasculitisWho this might be right forANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more Assistance Publique - Hôpitaux de Paris 146
Not applicableStudy completedNCT00001393What this trial is testingGenetic Markers for Focal Segmental GlomerulosclerosisWho this might be right forFocal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Testing effectiveness (Phase 2)Study completedNCT02592798What this trial is testingPilot Study to Evaluate the Safety and Efficacy of Abatacept in Adults and Children 6 Years and Older With Excessive Loss of Protein in the Urine Due to Either Focal Segmental Glomerulosclerosis (FSGS) or Minimal Change Disease (MCD)Who this might be right forNephrotic SyndromeFocal Segmental GlomerulosclerosisMinimal Change Disease Bristol-Myers Squibb 36
Not applicableLooking for participantsNCT06162546What this trial is testingARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and BiobankWho this might be right forFocal Segmental GlomerulosclerosisProteinuriaNephrotic Syndrome+1 more Christoph Aufricht 100
Testing effectiveness (Phase 2)Looking for participantsNCT06466135What this trial is testingStudy of WAL0921 in Patients With Glomerular Kidney DiseasesWho this might be right forDiabetic NephropathiesPrimary Focal Segmental GlomerulosclerosisMinimal Change Disease+2 more Walden Biosciences 96
Large-scale testing (Phase 3)Study completedNCT02683889What this trial is testingUse of Acthar in Patients With FSGS That Will be Undergoing Renal TransplantationWho this might be right forFSGS University of Colorado, Denver 15
Not applicableStudy completedNCT06766786What this trial is testingMagnesium Supplementation in Simultaneous Pancreas-Kidney TransplantationWho this might be right forRenal Failure Chronic Requiring DialysisDiabetes Mellitus, with ComplicationsGlomerulosclerosis+3 more Dr Olu Bamgbade, MD, FRCPC 40
Not applicableLooking for participantsNCT02235857What this trial is testingPost Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in ChildrenWho this might be right forFocal Segmental Glomerulosclerosis Kaneka Medical America LLC 35
Testing effectiveness (Phase 2)Ended earlyNCT01113801What this trial is testingA Study in Participants With Diabetic Kidney DiseaseWho this might be right forDiabetic Kidney DiseaseDiabetic NephropathyDiabetic Glomerulosclerosis Eli Lilly and Company 417
Testing effectiveness (Phase 2)Looking for participantsNCT06500702What this trial is testingEvaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change DiseaseWho this might be right forFocal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion Sanofi 84
Testing effectiveness (Phase 2)Study completedNCT03536754What this trial is testingCCX140-B in Subjects With FSGSWho this might be right forFSGSFocal Segmental GlomerulosclerosisGlomerulosclerosis Amgen 46
Testing effectiveness (Phase 2)WithdrawnNCT00550342What this trial is testingRituximab Treatment of Focal Segmental GlomerulosclerosisWho this might be right forFocal Segmental Glomerulosclerosis (FSGS) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Post-approval studies (Phase 4)Study completedNCT02585804What this trial is testingTreating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial EffectsWho this might be right forFocal Segmental Glomerulosclerosis University Health Network, Toronto 10
Early research (Phase 1)Study completedNCT05562362What this trial is testingStudy to Evaluate the Pharmacokinetics of Oral Sparsentan SuspensionWho this might be right forHealthy Subjects Travere Therapeutics, Inc. 47
Not applicableLooking for participantsNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375